Market Research Forecast released a new market study on Global Nuclear Medicine/ Radiopharmaceuticals Market Research report which presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for Global Nuclear Medicine/ Radiopharmaceuticals Forecast till 2032.
The Nuclear Medicine/ Radiopharmaceuticals Marketsize was valued at USD 7.53 USD billion in 2023 and is projected to reach USD 26.20 USD billion by 2032, exhibiting a CAGR of 19.5 % during the forecast period.
Key Players included in the Research Coverage of Nuclear Medicine/ Radiopharmaceuticals Market are Lantheus Medical Imaging, Inc. (U.S.), Cardinal Health (U.S.), Norgine B.V. (Netherlands), Nordion (Canada) Inc. (Canada), Bayer AG (Germany), Curium (France), Advanced Accelerator Applications (Novartis AG) (France), Bracco Diagnostic Inc. (U.S.), Jubilant Pharmova Limited (India), GE Healthcare (General Electric Company) (U.S.)
What's Trending in Market: Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
Market Growth Drivers: How has Increasing Prevalence of Obesity Propelled the Market Growth?
GET FREE SAMPLE PDF ON Nuclear Medicine/ Radiopharmaceuticals MARKET
The Global Nuclear Medicine/ Radiopharmaceuticals Market segments and Market Data Break Down Type: Diagnostic and Therapeutic, Application: Neurology, Cardiology, Oncology, and Others, End-user: Hospitals & Clinics, Diagnostic Centers, and Others
To comprehend Global Nuclear Medicine/ Radiopharmaceuticals market dynamics in the world mainly, the worldwide Nuclear Medicine/ Radiopharmaceuticals market is analyzed across major global regions. AMA also provides customized specific regional and country-level reports for the following areas.
• North America: United States, Canada, and Mexico.
• South & Central America: Argentina, Chile, Colombia and Brazil.
• Middle East & Africa: Saudi Arabia, United Arab Emirates, Israel, Turkey, Egypt and South Africa.
• Europe: United Kingdom, France, Italy, Germany, Spain, Belgium, Netherlands and Russia.
• Asia-Pacific: India, China, Japan, South Korea, Indonesia, Malaysia, Singapore, and Australia.
Strategic Points Covered in Table of Content of Global Nuclear Medicine/ Radiopharmaceuticals Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Nuclear Medicine/ Radiopharmaceuticals market
Chapter 2: Exclusive Summary – the basic information of the Nuclear Medicine/ Radiopharmaceuticals Market.
Chapter 3: Changing Impact on Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Nuclear Medicine/ Radiopharmaceuticals;
Chapter 4: Presenting the Nuclear Medicine/ Radiopharmaceuticals Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2017-2022
Chapter 6: Evaluating the leading manufacturers of the Nuclear Medicine/ Radiopharmaceuticals market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2023-2028)
…………….
More Reports:
https://marketresearchforecast.com/reports/nuclear-medicine-radiopharmaceuticals-market-798
https://marketresearchforecast.com/reports/colorectal-cancer-screening-market-836
For More Information Please Connect MR Forecast
Contact US:
Craig Francis (PR & Marketing Manager)
Market Research Forecast
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: (+1 201 565 3262, +44 161 818 8166)
[email protected]
